Renaissance Investment Group’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | – | Sell |
-32,699
| Closed | -$2.26M | – | 80 |
|
|
2025
Q2 | $2.26M | Buy |
32,699
+2,498
| +8% | +$170K | 0.49% | 37 |
|
|
2025
Q1 | $2.1M | Buy |
30,201
+1,376
| +5% | +$114K | 0.51% | 38 |
|
|
2024
Q4 | $2.48M | Sell |
28,825
-12,748
| -31% | -$1.38M | 0.52% | 40 |
|
|
2024
Q3 | $4.95M | Buy |
41,573
+932
| +2% | +$124K | 1.03% | 36 |
|
|
2024
Q2 | $5.71M | Buy |
40,641
+1,203
| +3% | +$159K | 1.24% | 34 |
|
|
2024
Q1 | $5.06M | Buy |
39,438
+4,344
| +12% | +$517K | 1.16% | 35 |
|
|
2023
Q4 | $3.63M | Buy |
35,094
+30,186
| +615% | +$2.99M | 0.9% | 39 |
|
|
2023
Q3 | $446K | Sell |
4,908
-40
| -0.8% | -$3.52K | 0.12% | 61 |
|
|
2023
Q2 | $400K | Hold |
4,948
| – | – | 0.11% | 63 |
|
|
2023
Q1 | $394K | Sell |
4,948
-48
| -1% | -$3.4K | 0.11% | 65 |
|
|
2022
Q4 | $338K | Sell |
4,996
-952
| -16% | -$55.8K | 0.1% | 65 |
|
|
2022
Q3 | $317K | Buy |
5,948
+812
| +16% | +$43.5K | 0.1% | 72 |
|
|
2022
Q2 | $286K | Hold |
5,136
| – | – | 0.09% | 72 |
|
|
2022
Q1 | $292K | Hold |
5,136
| – | – | 0.09% | 77 |
|
|
2021
Q4 | $288K | Buy |
5,136
+136
| +3% | +$7.37K | 0.07% | 73 |
|
|
2021
Q3 | $240K | Hold |
5,000
| – | – | 0.06% | 76 |
|
|
2021
Q2 | $209K | Buy |
+5,000
| New | +$194K | 0.05% | 83 |
|
|
2019
Q2 | – | Sell |
-8,392
| Closed | -$219K | – | 91 |
|
|
2019
Q1 | $219K | Buy |
+8,392
| New | +$206K | 0.09% | 77 |
|
|
2018
Q2 | – | Sell |
-8,400
| Closed | -$207K | – | 85 |
|
|
2018
Q1 | $207K | Sell |
8,400
-100
| -1% | -$2.63K | 0.08% | 84 |
|
|
2017
Q4 | $228K | Sell |
8,500
-100
| -1% | -$2.54K | 0.09% | 78 |
|
|
2017
Q3 | $207K | Buy |
+8,600
| New | +$194K | 0.09% | 77 |
|
|
2016
Q4 | – | Sell |
-9,660
| Closed | -$201K | – | 81 |
|
|
2016
Q3 | $201K | Sell |
9,660
-240
| -2% | -$5.95K | 0.1% | 78 |
|
|
2016
Q2 | $266K | Hold |
9,900
| – | – | 0.13% | 67 |
|
|
2016
Q1 | $268K | Hold |
9,900
| – | – | 0.13% | 68 |
|
|
2015
Q4 | $287K | Hold |
9,900
| – | – | 0.14% | 67 |
|
|
2015
Q3 | $268K | Sell |
9,900
-100
| -1% | -$2.83K | 0.14% | 64 |
|
|
2015
Q2 | $274K | Sell |
10,000
-300
| -3% | -$8.43K | 0.13% | 64 |
|
|
2015
Q1 | $275K | Sell |
10,300
-200
| -2% | -$4.61K | 0.13% | 65 |
|
|
2014
Q4 | $222K | Hold |
10,500
| – | – | 0.1% | 72 |
|
|
2014
Q3 | $250K | Hold |
10,500
| – | – | 0.12% | 71 |
|
|
2014
Q2 | $242K | Hold |
10,500
| – | – | 0.12% | 70 |
|
|
2014
Q1 | $240K | Sell |
10,500
-400
| -4% | -$8.52K | 0.12% | 68 |
|
|
2013
Q4 | $201K | Buy |
+10,900
| New | +$190K | 0.1% | 72 |
|
Other funds holding NVO
F
Renaissance Investment Group's NVO Position: Q3 2025 in Review
Renaissance Investment Group sold out of Novo Nordisk (NVO) in Q3 2025, closing a stake of 32,699 shares — an estimated $2.26M sold.
Renaissance Investment Group first reported a position in NVO in Q4 2013 and held it in 33 quarters. The position peaked at $5.71M in Q2 2024. 1,395 funds tracked by Wall St. Rank hold NVO as of Q3 2025.
- Renaissance Investment Group reported no remaining Novo Nordisk position as of Q3 2025 after selling out during the quarter.
- Renaissance Investment Group sold 32,699 Novo Nordisk shares in Q3 2025, an estimated $2.26M.
- Renaissance Investment Group first reported a position in Novo Nordisk in Q4 2013 and held it in 33 quarters.
- Renaissance Investment Group's Novo Nordisk position peaked at $5.71M in Q2 2024.
- 1,395 funds tracked by Wall St. Rank held Novo Nordisk as of Q3 2025.
Based on Renaissance Investment Group's 13F filing for Q3 2025, filed 7 Oct 2025.